Dr. Ravindra Kolhe is a Leon Henri Charbonnier Endowed Chair of Pathology at Augusta University and is the inaugural Associate Dean for translation research at Medical College of Georgia. He also serves as the Associate Cancer Center Director for Genomics at the Georgia Cancer Center. Currently, Kolhe leads an NCI-designated translational pathology laboratory for MATCH testing which is focused on comprehensive genomic testing in oncology. He co-founded a consortium (SEQUOIA) of 40+ clinical laboratories across the globe for the democratization of NGS testing in oncology & successfully helped multiple labs to bring NGS testing in-house. He served on the Georgia Governor’s Task Force for COVID-19 and successfully led the COVID-19 screening program for the State of Georgia during the early Pandemic. Kolhe is also a co-founder of a COVID-19 Host Genome Structural Variation Consortium and coordinated a global network of researchers who are contributing to our collective knowledge on host genome response to the SARS-CoV-2 infection and COVID-19 disease. He has led several studies, focused on adapting and validating newer technologies (NGS, RNA-seq, OGM, etc) in CLIA laboratories by establishing PLA & Z-codes and reimbursement. He has authored more than 90+ peer-reviewed publications and serves on multiple CAP committees and scientific advisory boards for numerous profit and non-profit organizations.